Original Article| Volume 90, ISSUE 1, P81-85, May 2000

Fast growing cervical carcinomas

A retrospective analysis of 20 IB–IIB FIGO


      Introduction: Fast growing cervix carcinomas have a pejorative outcome: they may occur quickly after cervical smears qualified as normal – within an interval from 12 to 18 months in women less than 50 years old, and involveing the endocervix. This retrospective analysis is aimed at assessing 5-year outcomes. Materials and methods: Twenty cases of fast-growing cancer of the uterine cervix classified according to the FIGO clinical staging system as IB (n=14), IIA (3), and IIB (3), have been reviewed and compared to a cohort of 160 cases not having this feature. As regard to fast-growing carcinoma, the median age was 41 years (range 25–50), and the median follow-up 22 months (8–213) as compared to 54 years (27–79) and 80 months (5–199) for the reference cohort. The comparison of the two cohorts shows only a difference of breakdown which concerns the histological pelvic lymph nodes status (P<0.05), more often positive in fast-growing forms. The treatment policy was equally distributed between a radio-surgical approach, cesium 137 intracavitary irradiation followed by radical hysterectomy and lymphadenectomy, or a definitive irradiation with pelvic external irradiation followed by cesium 137 intracavitary irradiation. Results: Thirteen deaths are reported in the fast-growing series instead of 54 in the other series. The 5-year overall survival is, respectively, 34 (13–55) vs. 74% (68–82) (P<0.001), the loco-regional-free survival 58 (33–84) vs. 85% (79–81) (P<0.001), the 5-year metastasis-free survival 61 (38–84) vs. 84% (78–90) (P=0.004). Conclusion: These poor results emphasize the need to intensify loco-regional therapy with a concurrent cisplatin-based chemotherapy within the framework of a multidisciplinary approach.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


        • IARC Working Group on Cervical Cancer Screening
        Summary chapter.
        in: Hakama M. Miller A.B. Day N.E. Screening for cancer of the uterine cervix. International Agency for Research on Cancer, Lyon1986: 133-142 (IARC Scientific Publ. No. 76)
        • De Brux J.
        Histoire naturelle des lésions pré-cancéreuses du col utérin.
        Bull Cancer. 1979; 66: 409-424
        • Bolla M.
        • Salvat J.
        • Favier M.
        • Racinet C.
        • Moulin J.J.
        • Vrousos C.
        La notion de poussée évolutive dans les cancers du col utérin. A propos de 3 observations.
        Bull Cancer. 1979; 66: 528-529
        • Bolla M.
        • Berland E.
        • Salvat J.
        Cancer du col utérin en poussée évolutive ou à croissance rapide. A propos d’une série de 14 observations.
        J Gynecol. 1993; 1: 407-411
        • Berkeley A.S.
        • LiVolsi V.A.
        • Schwartz P.E.
        Advanced squamous cell carcinoma of the cervix with recent normal Papanicolaou tests.
        Lancet. 1980; 2: 375-376
        • Beuret Th.
        • Sadoul G.
        • Barbageletta M.
        • De Brux J.
        Carcinomes in situ et invasif du col utérin d’apparition rapide.
        J Gynecol Obstet Biol Reprod. 1983; 12: 147-154
        • Dargent D.
        • Gérard J.P.
        • Chabert Ph.
        • Adeleine P.
        Place de la radiothérapie intra-opératoire(R.I.O.) dans le traitement du cancer utérin.
        J Gynecol. 1993; 1: 120-127
        • Horiot J.C.
        • Pigneux J.
        • Pourquier H.
        • Schraub S.
        • Achille E.
        • Keiling R.
        • Combes P.
        • Rozan R.
        • Vrousos C.
        • Daly N.
        Radiotherapy alone in carcinoma of the intact uterine cervix according to G.H. Fletcher guidelines. A French cooperative study of 1343 cases.
        Int J Radiat Oncol Biol Phys. 1988; 14: 605-611
      1. Berland E, Analyse rétrospective de 239 cas de carcinomes du col utérin: étude de la survie du controle locorégional, de la rémission métastatique, des facteurs pronostiques et les complications. Thèse de Doctorat en Médecine, 1994.

        • Bolla M.
        • Salvat J.
        • Sarrazin R.
        • Dyon J.F.
        • Berland E.
        • Schmidt M.H.
        • de Cornelier J.
        • Huy Quoc T.D.
        • Rolachon I.
        Feasability of retroperitoneal pelvic lymph node exploration in cervical carcinoma. Assessment of morbidity in 33 cases treated by combined radio-surgery or definitive radiotherapy.
        Radiother Oncol. 1996; 40: 233-239
        • International Commission on Radiation Units and Measurements
        Dose and volume specification for reporting intracavitary therapy in oncology. ICRU, 1985 (Rapport No. 38)
        • Piver M.S.
        • Rutledge F.N.
        • Smith J.P.
        Five classes of extended hysterectomy for women with cervical cancer.
        Obstet Gynecol. 1974; 44: 265-272
        • Kaplan E.L.
        • Meier P.
        Nonparametric estimation from incomplete observations.
        J Am Stat Assoc. 1958; 53: 457-481
        • Rylander R.
        Negative smears in women developing invasive cervical cancer.
        Acta Obstet Gynecol Scand. 1977; 56: 115-118
        • Peters R.K.
        • Thomas D.
        • Skultin G.
        • Henderson B.E.
        Invasive squamous cell carcinoma of the cervix after recent negative cytologic test results. A distinct subgroup?.
        Am J Obstet Gynecol. 1988; 158: 926-935
        • Barillot I.
        • Horiot J.C.
        • Pigneux J.
        • Schraub S.
        • Rozan R.
        • Daly N.
        • Bolla M.
        • Pourquier H.
        Carcinomes du col utérin de la femme jeune: étude du groupe coopérateur français.
        Bull Cancer Radiother. 1994; 81: 432-436
        • Michel G.
        • Castaigne D.
        • Morice P.
        • Des Noettes R.
        • Rey A.
        • Gerbaulet A.
        • Lhommé C.
        • Prade M.
        Le cancer invasif du col utérin de la femme jeune aux stades I et II: expérience de l’Institut Gustave Roussy.
        Bull Cancer Radiother. 1994; 81: 418-426
      2. Dargent D. Salvat J. Envahissement ganglionnaire pelvien. Place de la pelviscopie rétropéritonéale. Medsi MacGraw Hill, Paris1989
        • Querleu D.
        • Leblanc E.
        • Castelain B.
        Lymphadénectomie pelvienne sous contrôle coelioscopique.
        J Gynecol Biol Reprod. 1990; 19: 576-578
        • Frigerio L.
        • Mariani A.
        • Gandini L.
        • Origoni M.
        • Rabaiotti E.
        • Aletti G.
        • Ferrari A.
        Prognostic factors in patients with locally advanced cervical cancer treated with radical hysterectomy and adjuvant radiotherapy.
        Int Surg. 1998; 83: 265-270
        • Querleu D.
        Laparoscopic paraaortic node sampling in gynecologic oncology: a preliminary experience.
        Gynecol Oncol. 1993; 49: 24-29
        • Resbeut M.
        • Hennequin C.
        Radiothérapie et chimiothérapie concomitante dans le traitement des cancers avancés du col utérin.
        Bull Cancer Radiother. 1994; 81: 437-445
        • National Cancer Institute
        Concurrent chemoradiation for cervical cancer. Clinical announcement. NCI, Washington, DC1999 (February 22)
        • Keys H.M.
        • Bundy B.N.
        • Stehman F.B.
        • Murderspach L.I.
        • Chafe W.E.
        • Suggs C.L.
        • Walker J.L.
        • Gersell D.
        Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma.
        N Engl J Med. 1999; 340: 1154-1161
        • Morris M.
        • Eifel P.J.
        • Lu J.
        • Grisby P.W.
        • Levenback C.
        • Stevens R.E.
        • Rotman M.
        • Gershenson D.M.
        • Mutch D.G.
        Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high risk cervical cancer.
        N Engl J Med. 1999; 340: 1137-1143
        • Rose P.G.
        • Bundy B.N.
        • Watkins E.B.
        • Thigpen J.T.
        • Deppe G.
        • Maiman M.
        • Clarke-Pearson D.L.
        • Insalaco S.
        Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer.
        N Engl J Med. 1999; 340: 1144-1153
        • Riou G.
        • Barrois M.
        • Lê M.G.
        • George M.
        • Le Doussal V.
        • Haie C.
        C-myc proto-oncogene expression and prognosis in early carcinoma of the uterine cervix.
        Lancet. 1987; i: 761-763
        • Riou G.
        • Favre M.
        • Jeannel D.
        • Bourhis J.
        • Le Doussal V.
        • Orth G.
        Association between poor prognosis in early stage invasive cervical carcinomas and non-detection of HPV DNA.
        Lancet. 1990; 335: 1171-1174